Drug intelligence / Profile preview

synthetic conjugated estrogens, B

Development stage
Approved
Lead developer
Teva Pharmaceutical Industries
Modality
Small Molecules
Administration
Oral
01

Overview

**Synthetic conjugated estrogens, B** is a defined oral estrogen-replacement product marketed under the brand name **Enjuvia**. It consists of a fixed 10-component blend of synthetic, water-soluble estrogen sulfate salts. After oral absorption, its estrogenic constituents activate estrogen receptors to replace diminished endogenous estrogen signaling after menopause. Enjuvia is FDA-approved for moderate-to-severe menopausal vasomotor symptoms and for moderate-to-severe vaginal dryness and dyspareunia associated with vulvar and vaginal atrophy due to menopause. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/021443s014lbl.pdf))

Brand names
Enjuvia
Other names
SCE-Bestrogens, conjugated synthetic B
02

Targets

ESR2 (ERβ)ESR1 (ERα)

Beyond the preview

Go deeper on synthetic conjugated estrogens, B.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on synthetic conjugated estrogens, B.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call